[Retracted] The Role of Gender-Related Immune Genes in Childhood Acute Myeloid Leukemia

Table 1

Result of evaluation.

	Description	value	KEGG	Description	value
BP	Response to lipopolysaccharide	2.35E-14	KEGG	Cytokine-cytokine receptor interaction	4.87E-20
BP	Response to molecule of bacterial origin	4.14E-14	KEGG	IL-17 signaling pathway	6.58E-09
BP	Cellular response to lipopolysaccharide	6.45E-13	KEGG	JAK-STAT signaling pathway	6.22E-08
BP	Cellular response to molecule of bacterial origin	9.61E-13	KEGG	Rheumatoid arthritis	1.15E-07
BP	Cellular response to biotic stimulus	3.42E-12	KEGG	Viral protein interaction with cytokine and cytokine receptor	2.03E-07
BP	Leukocyte chemotaxis	9.23E-10	KEGG	TNF signaling pathway	4.88E-07
BP	Cell chemotaxis	1.13E-09	KEGG	Legionellosis	2.98E-05
BP	Antimicrobial humoral response	7.96E-11	KEGG	Amoebiasis	4.50E-05
BP	Granulocyte chemotaxis	2.65E-09	KEGG	Chemokine signaling pathway	0.00021
BP	Antimicrobial humoral immune response mediated by antimicrobial peptide	1.82E-09	KEGG	Malaria	0.000285
CC	Collagen-containing extracellular matrix	1.58E-05	KEGG	Inflammatory bowel disease	0.000779
CC	Secretory granule lumen	2.95E-05	KEGG	Transcriptional misregulation in cancer	0.001381
CC	Cytoplasmic vesicle lumen	3.19E-05	KEGG	Pertussis	0.001402
CC	Vesicle lumen	3.32E-05	KEGG	EGFR tyrosine kinase inhibitor resistance	0.001618
CC	Golgi lumen	0.000188	KEGG	African trypanosomiasis	0.001685
CC	Tertiary granule lumen	0.000486	KEGG	Measles	0.001922
CC	Specific granule lumen	0.000691	KEGG	Phospholipase D signaling pathway	0.00253
CC	External side of plasma membrane	0.000767	KEGG	MAPK signaling pathway	0.002611
CC	Endoplasmic reticulum lumen	0.001677	KEGG	TGF-beta signaling pathway	0.00306
MF	Receptor ligand activity	1.38E-28	KEGG	Hematopoietic cell lineage	0.003689
MF	Signaling receptor activator activity	1.83E-28	KEGG	AGE-RAGE signaling pathway in diabetic complications	0.003824
MF	Cytokine activity	2.34E-23	KEGG	Chagas disease	0.004106
MF	Cytokine receptor binding	3.65E-21	KEGG	Toll-like receptor signaling pathway	0.004401
MF	Growth factor activity	6.99E-19	KEGG	Tuberculosis	0.005838
MF	Growth factor receptor binding	2.09E-10	KEGG	Axon guidance	0.005975
MF	Chemokine receptor binding	9.74E-10	KEGG	NOD-like receptor signaling pathway	0.005975
MF	Chemokine activity	6.83E-09	KEGG	PI3K-Akt signaling pathway	0.007218
MF	G protein-coupled receptor binding	1.32E-07	KEGG	Kaposi sarcoma-associated herpesvirus infection	0.0078
MF	Transforming growth factor beta receptor binding	1.61E-05	KEGG	Cortisol synthesis and secretion	0.008345
			KEGG	Osteoclast differentiation	0.009117